Table: Pharmarise Holdings -Q1 group results

Pharmarise Holdings

25/09/2024 09:00

Sept 25 (Reuters)- 
             Pharmarise Holdings Corp 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   3 months ended      3 months ended       Year to 
                  Aug 31, 2024        Aug 31, 2023     May 31, 2025 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               15.23               13.47            60.88    
                   (+13.1 pct)         (+4.7 pct)       (+11.8 pct) 
  Operating          52 mln              331 mln          949 mln   
                   (-84.1 pct)         (-5.0 pct)       (+3.6 pct)  
  Recurring          23 mln              331 mln          804 mln   
                   (-93.0 pct)         (-2.8 pct)       (-3.4 pct)  
  Net             loss 131 mln           123 mln          40 mln    
                                       (+11.2 pct)                  
  EPS            loss 11.68 yen         13.11 yen        3.63 yen   
  EPS Diluted                           9.93 yen                    
  Ann Div                               20.00 yen        14.00 yen  
  -Q2 div                                  NIL              NIL     
  -Q4 div                               20.00 yen        14.00 yen  
  
  NOTE - Pharmarise Holdings Corp. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2796.T